argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
717.79
-10.32 (-1.42%)
At close: Mar 6, 2026, 4:00 PM EST
708.67
-9.12 (-1.27%)
After-hours: Mar 6, 2026, 7:56 PM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $44.16 billion as of March 6, 2026. Its market cap has increased by 14.07% in one year.
Market Cap
44.16B
Enterprise Value
39.83B
1-Year Change
14.07%
Ranking
Category
Stock Price
$717.79
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $44.16B, an increase of 7,046.35%. That is a compound annual growth rate of 62.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 44.00B | -14.28% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 78.50B |
| Alnylam Pharmaceuticals | 42.51B |
| BeOne Medicines AG | 32.50B |
| Insmed | 30.95B |
| Royalty Pharma | 26.35B |
| BioNTech SE | 25.58B |
| Roivant Sciences | 21.27B |
| Moderna | 21.26B |